iPSCs-BBB研究所

iPSCs-BBB研究所

Open Menu

Obtaining research funds and external funds

2024

Period  :2024
Title:Validation of Treatment for Multiple Sclerosis
Organization  :Innovative Drug Discovery and Development Booster
Link  :https://www.amed.go.jp/en/program/list/11/02/001_01-01.html

2023

Period  :2023-2027
Title:JSPS Leading Initiative for Excellent Young Researcher
Organization  :JSPS Leading Initiative for Excellent Young Researcher
Link  :https://www.jsps.go.jp/j-le/koubo_kenkyu.html
Period  :2023-2025
Title:Investigating blood-brain barrier dysfunction in patient with
hereditary cerebral small vessel disease pathogenesis for
the understanding of dementia and stroke
Organization  :Japan Agency for Medical Research and Development (AMED)
Link  :https://www.amed.go.jp/koubo/13/01/1301C_00025.html
Period  :2023-2025(フェーズ1)
Title:Blood-brain barrier as a therapeutic and diagnostic target
Organization  :Fusion Oriented Research for disruptive Science and Technology,
Link  :https://www.jst.go.jp/souhatsu/research/panel_mizushima.html
Period  :2023/4-2025/3
Title:Investigate pathomechanisms of neurological diseases focusing
on blood-brain barrier dysfunction
Organization  :Kato Memorial Bioscience Foundation
Link  :https://www.katokinen.or.jp/wordpress/wp-content/uploads/2023/02/34ken_jyoseisya.pdf
Period  :2023/4 -2025/3
Title:Establishment of patient-derived blood-brain barrier model for
the study of pathomechanisms and development of drugs
targeting blood-brain barrier
Organization  :The YMFG Regional Enterprise Support Foundation
Link  :https://ymfg-josei.jp
Period  :2023/4 -2024/3
Title:Blood-brain barrier as a novel therapeutic strategy for the neurodegeneration
Organization  :Co-Create Knowledge for Pharma Innovation with Takeda (COCKPI-T®) Funding
Link  :https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t
Period  :2023/1 – 2025/12
Title:Exploring if intrisic blood-brain barrier dysfunction contributes to
multiple sclerosis pathogenesis
Organization  :Swiss National Science Foundation (SNSF)/ Japan Society for the Promotion
of Science (JSPS) JSPS INTERNATIONAL JOINT RESEARCH PROGRAM
Link  :https://www.jsps.go.jp/j-bottom/04_g_jyoukyou.html
Period  :2023-2025
Title:Establishment of Amyotrophic Lateral Sclerosis patient-derived
Blood Brain Barrier model to investigate the pathogenesis
Organization  :Yamaguchi Institute of Gerontology
Link  :http://www.tip.ne.jp/rounenkenkyu/jyosei/backnumber.html
Period  :2023-2024
Title:Generation of a blood-brain barrier model for amyotrophic lateral
sclerosis patients using iPS cells
Organization  :New Frontier Project at Yamaguchi University
Link  :
Period  :2023/10-2024/9
Title:Developing a Novel Treatment for ALS by Targeting the Blood-Brain Barrier
Organization  :THE YUKIHIKO MIYATA MEMORIAL TRUST FOR ALS RESEARCH
Link  :
Period  :2023/1 – 2023/12
Title:Elucidation of the pathomechanism of neurodegeneration focusing
on the blood-brain barrier
Organization  :Life Science Foundation of Japan
Link  :https://www.lifesci-found.com
Period  :2023/1- 2023/12
Title:Establishment of Amyotrophic Lateral Sclerosis patient-derived
Blood Brain Barrier model for the development therapeutics
Organization  :iPS Academia Japan
Link  :https://ips-cell.net/j/

2022

Period  :2022/8 – 2027/12
Title:Targeting blood-brain barrier for the treatment of neuroinflammatory and
neurodegenerative disease
Organization  :Takeda Science Foundation
Link  :https://www.takeda-sci.or.jp
Period  :2022/4 – 2024/3
Title:Identification of genetic risk of blood-brain barrier dysfunction in Japanese
Multiple Sclerosis patients
Organization  :Grants-in-Aid for Scientific Research by JSPS
Link  :https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K15711/
Period  :2022-2023
Title:患者由来血液脳関門を用いたCADASIL
(cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
の病態解明と血液脳関門という新たな治療標的の確立
Organization  :FOCS project at Yamaguchi University
Link  :
Period  :2022/11 – 2023/3
Title:Is there a genetic predisposition to disrupt the blood-brain barrier
in Japanese patients with multiple sclerosis?
Organization  :Japan Multiple Sclerosis Society
Link  :http://www.jmss-s.jp
Period  :2022/11 – 2023/3
Title:Targeting blood-brain barrier stabilization for treatment
of neuroinflammatory and neurodegenerative diseases
Organization  :YOKOYAMA Foundation for Clinical Pharmacology
Link  :https://yokoyama-fdn.or.jp
Period  :2022/10 – 2023/9
Title:Contribution of blood-brain barrier on neurological disease
Organization  :Ichiro Kanehara Foundation
Link  :https://www.kanehara-zaidan.or.jp
Period  :2022/7 – 2023/6
Title:Development of blood-brain barrier targeting drugs based
on iPSCs-derived models
Organization  :Narishige Neuroscience Research Foundation
Link  :https://www.narishige.co.jp/japanese/fund/
Period  :2022/4 – 2023/3
Title:Investigate genetic burden of blood-brain barrier dysfunction
in Multiple Sclerosis patients
Organization  :NOVARTIS Foundation
Link  :https://japanfoundation.novartis.org
Period  :2022-2023
Title:多発性硬化症患者の血液脳関門破綻の遺伝学的素因の解明
Organization  :山口大学基金「若手研究者による研究プロジェクトに対する支援事業」
Link  :https://ds0n.cc.yamaguchi-u.ac.jp/~kikin5622/
Period  :2022/1- 2022/12
Title:Investigation of genetic risk of blood-brain barrier dysfunction
in Multiple Sclerosis patients
Organization  :Research grant of Uehara Memorial Foundation
Link  :https://ds0n.cc.yamaguchi-u.ac.jp/~kikin5622/
Period  :2022 – 2023
Title:皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症(CADASIL)
Organization  :AMED: 疾患特異的iPS細胞の利活用促進・難病研究加速プログラム
「iPS細胞を用いた希少疾患の研究促進のための研究者マッチング課題」
Link  :https://www.amed.go.jp/news/program/202200425_iPS-disease-matching.html

2021

Period  :2021- 2022
Title:中枢神経の扉を開く:疾患由来血液脳関門モデルを用いたアプローチ
Organization  :FOCS project at Yamaguchi University
Link  :